Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Income from Non-Controlling Interests: 2010-2023

Historic Income from Non-Controlling Interests for Ironwood Pharmaceuticals (IRWD) over the last 1 years, with Dec 2023 value amounting to -$658,000.

  • Ironwood Pharmaceuticals' Income from Non-Controlling Interests was N/A to -$658,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$579,000, marking a year-over-year change of. This contributed to the annual value of -$29.3 million for FY2023, which is N/A change from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Income from Non-Controlling Interests of -$658,000 as of Q4 2023, which was up 52.01% from -$1.4 million recorded in Q3 2023.
  • Ironwood Pharmaceuticals' Income from Non-Controlling Interests' 5-year high stood at -$658,000 during Q4 2023, with a 5-year trough of -$1.4 million in Q3 2023.
  • In the last 1 years, Ironwood Pharmaceuticals' Income from Non-Controlling Interests had a median value of -$1.0 million in 2023 and averaged -$1.0 million.